Observations on spinal muscular atrophy in context of treatment with Nusinersen : a neuropsychological approach
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Ulm, Universität Ulm, Dissertation, 2021
- Keyword
-
Spinal muscular atrophy
Social perception
Physiology
Chemotherapy
Muscular atrophy
Spinale Muskelatrophie
Soziale Wahrnehmung
Exekutive Funktionen
Kognitive Entwicklung
- DOI
-
10.18725/OPARU-40296
- URN
-
urn:nbn:de:bsz:289-oparu-40372-8
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mix, Lucas Phillip
- Universität Ulm
Time of origin
- 2021
Other Objects (12)
Nusinersen: A Review in 5q Spinal Muscular Atrophy
Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
Correction to: Nusinersen: A Review in 5q Spinal Muscular Atrophy
Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy
Evaluation of Metabolic Effects of Nusinersen in Patients with Spinal Muscular Atrophy
Experiences from treating seven adult 5q spinal muscular atrophy patients with Nusinersen
Profiling neuroinflammatory markers and response to nusinersen in paediatric spinal muscular atrophy
Spinal muscular atrophy
Proteomics profiling and machine learning in nusinersen-treated patients with spinal muscular atrophy
Intrathecal administration of nusinersen for spinal muscular atrophy: report of three cases with severe spinal deformity
Treatment expectations and patient-reported outcomes of nusinersen therapy in adult spinal muscular atrophy
Nusinersen: A Review in 5q Spinal Muscular Atrophy
Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
Correction to: Nusinersen: A Review in 5q Spinal Muscular Atrophy
Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy
Evaluation of Metabolic Effects of Nusinersen in Patients with Spinal Muscular Atrophy
Experiences from treating seven adult 5q spinal muscular atrophy patients with Nusinersen
Profiling neuroinflammatory markers and response to nusinersen in paediatric spinal muscular atrophy
Spinal muscular atrophy
Proteomics profiling and machine learning in nusinersen-treated patients with spinal muscular atrophy
Intrathecal administration of nusinersen for spinal muscular atrophy: report of three cases with severe spinal deformity
Treatment expectations and patient-reported outcomes of nusinersen therapy in adult spinal muscular atrophy
Nusinersen: A Review in 5q Spinal Muscular Atrophy
Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
Correction to: Nusinersen: A Review in 5q Spinal Muscular Atrophy
Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy
Evaluation of Metabolic Effects of Nusinersen in Patients with Spinal Muscular Atrophy
Experiences from treating seven adult 5q spinal muscular atrophy patients with Nusinersen
Profiling neuroinflammatory markers and response to nusinersen in paediatric spinal muscular atrophy
Spinal muscular atrophy
Proteomics profiling and machine learning in nusinersen-treated patients with spinal muscular atrophy
Intrathecal administration of nusinersen for spinal muscular atrophy: report of three cases with severe spinal deformity